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Abstract: The consumption of tea originated in ancient China over 4000 years ago and is
currently the second most popular beverage in the world after water. Tea is an aromatic
beverage prepared by pouring hot water over cured leaves of the Camellia sinensis plant.
The link between tea intake, most notably green tea, and health has resulted in intense
research on the components responsible for preventing the onset of several chronic diseases,
including atherosclerosis, cancer, obesity and diabetes. In particular, the high levels of
chemically diverse phenols (e.g., phenolic acids, flavonoids) present in tea exhibit potent
protective properties against many of these diseases. Although health related research on
green tea and its predominant phenol (catechins) has been on-going for decades, major
advances have occurred in the last 5–10 years. Therefore, this review focuses on seminal
studies reported primarily within the last five years but not extending past ten years on the
link between health and green tea with an emphasis on the catechins.
Keywords: green tea; phenols; flavonoids; oxidative stress; inflammation; health; catechins

1. Introduction
Tea originated in China over 4000 years ago and has since been a popular luxury commodity by
the Asian population valued for its taste, aroma, medicinal applications, and cultural history [1]. The
golden age of tea occurred during the Tang Dynasty (A.D. 618–906) as cultivation and trading routes
expanded outside of China. The tea rules and ceremony developed by Lu Yu (733–804) as described in
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Cha Chang or The Classic of Tea led to the earliest treatise on tea. Steaming of the leaves became the
normal custom along with specific guidelines for processing the leaves and brewing the beverage. Lu
Yu’s work transformed the process into an art form and set the standard for tea cultivation/production
in China. This ceremony eventually became the model that would emerge in Japan [2,3]. Tea arrived in
Japan and Korea during the 6th century resulting in another highly sustainable market. Tea was
subsequently introduced to Indonesia and India and then followed the trade routes into Europe (~1610),
most notably Holland and England. At this point in world history, tea was considered such a high
valued commodity that it was used for currency and international trade [2,3]. Tea is now cultivated in
more than sixty countries with Asia (China, India, Japan, Sri Lanka, and Taiwan) producing more than
91% of the total amount annually (Table 1) [4]. While fermentation has aided in the ease of exporting
tea and is a principal factor for the West’s preference for black tea, green tea, or unfermented tea, is
preferred in the East. However, tea drinking in North America and the Middle East of any kind is still
comparatively low relative to China, Japan, and other European countries.
Table 1. Average annual tea production quantities by country (2005 to 2010).
Country
China
India
Kenya
Sri Lanka
Turkey
Viet Nam
Indonesia
Iran
Japan
Argentina
Thailand
Bangladesh
Malawi
Uganda
United Republic of Tanzania

Quantities (tons)
1,217,039
963,313
344,596
304,036
209,535
167,531
154,328
108,751
92,233
76,071
59,203
58,763
46,155
41,543
31,850

Data from FAO database (http://faostat3.fao.org/home/index.html [5]).

Green tea (GT) is made from the leaf of Camellia sinensis and is typically cultivated in hot humid
climates [4]. Harvesting of high quality GT can simply be described as “two leaves and a bud” plucked
from every new shoot. The process of GT production (Figure 1) preserves many compounds that have
been linked to multiple human health properties making GT stand out from fermented black and
semi-fermented oolong tea. As such, GT and its extracts have been used to enrich energy drinks, juices,
vitamins, and other food systems. Of the health benefiting agents present in GT, the catechins have
received major research focus [6,7]. Therefore, instead of attempting to summarize the wealth of
literature published in this area, seminal studies reported primarily from the last five years but not
extending past ten years will be reviewed with an emphasis on the GT catechins.
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Figure 1. Tea production and its influence on the final polyphenols content (adapted from
Cabrera et al. [8]).

2. Composition of Green Tea
Green tea is a rich source of health promoting components (nutraceuticals or bioactives) largely due
to its high levels of chemically diverse phenolic compounds, which account for ~30% and 50% of the
GT leaf and beverage on a dry weight basis, respectively (Figure 2).
Figure 2. Principal components of green tea leaf and green tea beverages (adapted from
Balentine et al. [9]).
Composition of green tea leaf (% dry weight)
Flavanols
Flavonols and flavonol glycosides
Phenolic acids and depsides
Other polyphenols
Caffeine
Theobromine
Amino acids
Organic acids
Monosaccharides
Polysaccharides
Cellulose
Protein
Lignin
Lipids
Chlorophyll and other pigments
Ash
Volatiles

3 0.5 5 0.1

6
15

25

7
3
5

13
4 0.5 4 0.23

3

Composition of green tea beverage (% wt/wt solids)
8
5
6
4

42

7
2
6
3

3

6

2 2

Catechins
Simple polyphenols
Flavonols
Other polyphenols
Theanine
Amino acids
Peptides/protein
Organic acids
Sugars
Other carbohydrates
Caffeine
Potassium
Other minerals/ash
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Flavan-3-ols are the major class of GT flavonoids with the catechins being the predominant
form [9], including (−)-epicatechin (EC), (−)-epicatechin gallate (ECG), (−)-epigallocatechin (EGC)
and (−)-epigallocatechin gallate (EGCG) (Figure 3). Among these compounds, EGCG represents
~59% of the total catechins [8]. Green tea also contains the phenolic acids, gallic acid, chlorogenic
acid and caffeic acid, and the flavonols, kaempferol, myricetin, quercetin and their conjugates
(Figure 2). Other flavonoids that account for a very small fraction of the tea have more recently
been identified and include 19 O-glycosylated flavonols, 7 C-glycosylated flavones, 28 acylated
glycosylated flavonols and 3 flavonols [10]. While not the focus of this review, it must be noted that
the fat soluble compounds present in GT, such as vitamin E and the carotenoids (2% dry weight) may
work with the phenols to enhance health benefits [8] albeit limited studies have been reported on
possible synergistic effects. Additionally, GT contains linoleic and linolenic acids (7% dry weight) [9],
which are only detected at trace levels after infusion as these compounds are involved in synthesizing
the essential oils that contribute to the “green odor” [11]. Monosaccharide and water-soluble
polysaccharides comprise nearly 20% of the GT leaf and are also compounds of interest due to their
links to health [9]. Lastly, polysaccharide conjugates have been isolated but their structures vary
depending on the origin of the tea [12,13].
Figure 3. Structure of major green tea flavonoids.
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3. Oxidative Stress
Reactive oxygen species (ROS), such as the hydroxyl radical (OH), superoxide (O2−) and hydrogen
peroxide (H2O2), maintain cellular homeostasis by acting as cell signaling agents or by regulating gene
expression [14,15]. If left unchecked however ROS imbalances can cause cellular oxidative
stress that can lead to chronic conditions and diseases, e.g., cancer, cardiovascular diseases and
neurodegenerative diseases. Reports have shown that GT and its predominant phenols (in isolation)
prevent or remediate oxidative stress via multiple mechanisms. A recent study by Schroeder et al. [16]
showed that the most abundant GT catechin (EGCG) protected the neuron by lowering levels of
mitochondrial free radicals and preventing apoptosis induced by oxidative stress. Guo et al. [17]
demonstrated that GT catechins fed to a 6-OHDA rat model presented with reduced levels of inducible
nitric oxide (NO) synthase and protein-bound 3-nitro-tyrosine. GT catechins also prevented ROS and
NO generation, lipid peroxidation and increased nitrite/nitrate ratio in a dose dependent manner. GT
polyphenols also play a role in reducing cellular levels of ROS generating redox-active metals.
Quesada et al. [18] determined that EGCG binds to zinc cations with high affinity thereby reducing the
accumulation of zinc in a human liver hepatocellular carcinoma (HepG2) cell model. Another study
reported by Wei and Meng [19] showed that EGCG reversed lead-induced oxidative damage in
ventricular myocytes isolated from rat hearts and reduced OH, O 2−, and H2O2 levels.
By acting as a pro-oxidant, GT has often been linked to the apoptotic induction of tumor cells [20].
Oxidative stress induced by GT polyphenols may also trigger endogenous antioxidant systems in
normal tissues. Maeta et al. [21] showed that 0.1% GT extract or 0.05% (1.1 mM) EGCG
produced H2O2 in yeast models grown in weak alkaline medium. Nuclear localization of
oxidative-stress-responsive transcription factors (Yap1 and Msn2 in S. cerevisiae, and Pap1 in
S. pombe) were subsequently activated. Elbling et al. [22] reported the autoxidation of EGCG resulted
in low-doses of H2O2, reduced DNA damage and cytotoxicity in keratinocyte-derived HaCat cell.
Additionally, these low levels of H2O2 initiated the up-regulation of antioxidant enzymes and lowered
ROS levels. The antioxidant and pro-oxidant effects of GT polyphenols may be linked to other health
benefits discussed in subsequent sections. A summary of this information and associated references are
provided in Table 2.
4. Inflammation
Inflammation is the body’s way of dealing with localized tissue damage/infection and is thus critical
to our survival. Yet, low grade but continued stimulation of the inflammatory response can lead to
chronic inflammation, which can then progress to coronary heart diseases, Alzheimer’s disease, type 2
diabetes, muscle degeneration, and cancer [23–25]. Many reports have shown the anti-inflammatory
properties of GT but the mechanisms eliciting the response vary between the studies.
Neutrophils are triggered at a specific site in the body by infections, tissue necrosis, necrotic cells,
foreign bodies-dirt, and immune signals, including those of chronic inflammation thereby contributing
to the inflammatory cycle. Dona et al. [26] reported that EGCG not only inhibited neutrophil elastase
in an in vitro model but also down-modulated ROS activity, caspase-3 activity, DNA fragmentation,
and the ability of neutrophiles to migrate towards a chemotactic stimulus. The in vivo part of this study
showed that EGCG inhibited neutrophil recruitment, inflammation-driven angiogenesis, and
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pulmonary fibrosis. Yet another in vivo study completed by Shen et al. [27] demonstrated that
fibrosis in female rats caused by chronic inflammation was significantly reduced when treated with
GT catechins.
Table 2. Recent studies on green tea and oxidative stress.
References

Model

Treatment

Schroeder et al.
[16]

Rat cerebellar granule
neurons cultures

EGCG

Guo et al.
[17]

6-hydroxydopamine
(6-OHDA)-treated rat
model of Parkinson’s
Disease

GTP (98%
purity)
containing 50%
EGCG, 22%
ECG, 18% EGC
and 10% EC

Quesada et al.
[18]

Wei & Meng
[19]

Maeta et al.
[21]

Elbling et al.
[22]

Human HepG2 cells

Myocytes from the
hearts of adult rats

Budding yeast S.
cerevisiae and fission
yeast S. pombe

Human keratinocytes

EGCG

EGCG

EGCG and GTE

EGCG

Dosage

Main outcomes

5, 10, or
20 μM

90%–95% of 3H-EGCG
accumulated in mitochondria.
EGCG treatments resulted in
reduced levels of free radicals and
protected neuron from apoptosis
induced by oxidative stress.

150, 450
mg/kg/
day-fed

GTP treatment dose-dependently
decreased ROS and NO level,
lipid peroxidation, nitrite/nitrate
ratio, and expression of inducible
nitric oxide synthase and
protein-bound 3-nitro-tyrosine.

10 μM

EGCG binded to zinc cations with
high affinity and thus reduced the
accumulation of zinc.

0–60 μg/mL

Formation of OH−, O2−, and H2O2
was decreased significantly as
EGCG concentration increased
compared to lead treated group.

0.05%
EGCG
0.1% GTE

H2O2 produced by EGCG and
GTE induced the expression of
nuclear localization of
oxidative-stress-responsive
transcription factors (Yap1 and
Msn2 in S. cerevisiae, and Pap1 in
S. pombe).

0–100 μM

Low-dose H2O2 and EGCG
treatment enhanced the clearance
of ROS and reduced DNA
damage and cytotoxicity in
keratinocyte-derived HaCat cell.

EGCG: (−)-epigallocatechin gallate; ECG: (−)-epicatechin gallate; EGC: (−)-epigallocatechin;
EC: (−)-epicatechin; GTP: green tea polyphenols; ROS: reactive oxygen species; NO: nitric oxide;
GTE: green tea extract; HaCAT: human keratinocyte line.
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Regulatory T cells (T-reg) are essential in maintaining immune functions by targeting sites of
sustained inflammation [28]. Recent in vitro and in vivo studies showed that EGCG (2–50 μM)
induced T-reg via the up-regulation of Foxp3, i.e., a transcription factor regulated by DNA
methylation [29]. The effect of EGCG on Foxp3 gene expression was similar to that of DNA
methyltransferase inhibitors. EGCG also inhibited nuclear factor-kappa B (NF-κB)-mediated
inflammatory responses in mice models via the Nrf2 antioxidant signaling pathway by increasing
systemic T-reg cell activity [30]. Wu et al. [31] investigated the ability of EGCG to suppress
proliferation of T-reg in the spleen of C57BL mice. The results indicated that 2.5 to 10 μM EGCG
inhibited T-reg proliferation but did not induce apoptosis or increase oxidative stress. These
researchers identified that the EGCG modulated pathway was related to IL-2/IL-2 receptor signaling.
Other mechanisms involving the inhibition of immune related cell signaling in response to
GT-polyphenols have been reported. Ranjith-Kumar et al. [32] showed that GT-EGCG can bind to the
retinoic acid inducible gene I (RIG-I) and thus interfere with interferon signaling response in
mammalian HEK293T cells. Moreover, this polyphenol was able to suppress ATPase activity of
recombinant RIG-I without competing with RIG-I and RNA or ATP. Analysis of the structure-activity
relationship of commercially available analogs revealed that RIG-I inhibitors included epimers
gallocatechin gallate and theaflavin 3,3’ digallate. EGCG was also shown to down regulate gene
expression related to macrophage migration. Using human keratinocytes, Noh and Park [33] reported
down regulation of the dexamethasone-induced macrophage migration inhibitory factor (MIF) in the
presence of EGCG and the expression of MIF-induced cytokines and chemokines, such as interleukin
(IL)-6, IL-18, transforming growth factor-β, CCL17, CCL22 and CXCL10, were subsequently
inhibited. Ripley et al. [34] reported that EGCG up-regulated STAT5 transcription factor and induced
the suppressor of cytokine signaling 1 gene through the superoxide pathway. These studies are
itemized in Table 3.
5. Cardiovascular Health
Studies have also increased on GT intake and the promotion of cardiovascular health [35,36].
Qin et al. [37] showed that GT polyphenols can alter the mRNA expression of the cardiac insulin
signaling pathway, regulate cardiac mRNA expression of cardiac lipid metabolism, and regulate the
inflammation-related gene expression in insulin resistant rats fed a high-fructose diet. These results
indicate the potential ability of GT to reduce the risk of coronary artery disease. Another study by
Lorenz et al. [38] compared stimulus NO production and vasodilation in response to GT and black tea
exposure. In the presence of the GT catechins, eNOS activity and vasorelaxation were induced by
activating and phosphorylating the signaling kinases in endothelial cells. Similar results were obtained
with black tea indicating that the theaflavins and thearubigins may be the responsible components.
El Bedoui et al. [39] also showed that EGCG inhibited matrix metalloproteinase-2 activity and thus
prevented vascular smooth muscle cell invasion.
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Table 3. Recent studies on green tea and inflammation.

References

Dona et al.
[26]

Model

Neutrophils and
C57 black mice

Treatment

EG CG

Dosage

Main Outcomes

1–100 μM

EGCG down-modulated ROS activity,
and inhibited apoptosis and chemotaxis
in vitro model. EGCG also inhibited
neutrophil recruitment, angiogenesis and
pulmonary fibrosis.

Shen et al. [27]

3-month-old
female rats

GTP (98.5%
purity)

0.5% in
water

The development of fibrosis in vessels
and myocardium in rat decreased
significantly with supplementation
via down-regulation of TNF-α
mRNA expression.

Wong et al. [29]

Human Jurkat
leukemic CD4+ T
cell line and
eight-week old
Balb/c male mice

EGCG
GT
beverage

2, 10, 50
μM
2%, w/v

EGCG induced expression of Foxp3 and
increased T-reg frequencies and
numbers both in vitro and in vivo.

Tsai et al. [30]

1 2-weeks-old
female NZB/W
F1 mice

EGCG

120 mg/kg
body weight

T-reg activity increased in EGCG
treated mice.

Wu et al. [31]

C57BL mice
spleen cells

2.5–10 μM

EGCG targeted the pathway which is
related to IL-2/IL-2 receptor signaling
and inhibited T cell proliferation.

Ranjith-Kumar
et al. [32]

Human
HEK293T cells

EGCG

0–10 μM

EGCG inhibited RIG-I by binding to
RIG-I and suppressing ATPase activity
of recombinant RIG-I.

Noh and Park
[33]

Human
keratinocytes

EGCG

100 μmol/L

EGCG down regulated MIF mRNA
expression and MIF induced cytokines
and chemokines.

Ripley et al. [34]

Monocytes of
human PBMCs
and SOC1deficient
C57BL/6 mice

0–200 μM

EGCG inhibited cytokine signaling
1 gene expression via inducing the
SOC1 expression and un-regulating
STAT5 transcription factor.

EGCG

GTE and
EGCG

EGCG: (−)-epigallocatechin gallate; GTP: green tea polyphenols; TNF-α: tumor necrosis factor alpha;
GT: green tea; IL-2: interleukin 2; RIG-I: retinoid-inducible gene 1; MIF: migration inhibitory factor;
PBMCs: peripheral blood mononuclear cells, GTE: green tea extract.
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Other studies have shown that GT polyphenols may function by modulating cholesterol metabolism.
Bursill and Roach [40] reported decreased cholesterol synthesis in HepG2 cells when incubated with
50 μM of GT-EGCG. However, cholesterol synthesis increased significantly using 200 μM of
GT-EGCG while cellular cholesterol remained at a low level. In the latter case, 30% more cholesterol
was detected in medium indicating that higher EGCG concentrations promoted the efflux of
cholesterol. Although the researchers used other GT catechins, GCG was the only catechin capable of
up regulating low-density lipoprotein (LDL) receptor activity [40]. Up-regulation of LDL receptor also
occurred in GT-polyphenolic fed cholesterol-fed rabbits [41]. Six experimental rabbits fed a 0.25%
(w/w) cholesterol diet for two weeks followed by catechin enriched diets supplemented of 0, 0.5, 1 or
2% (w/w) for four weeks showed up-regulation of LDL receptor activity and a 60% reduction in
plasma cholesterol (80% in LDL cholesterol).
Multiple human clinical studies have been completed to determine the anti-arthrosclerosis benefits
of GT consumption. In one study [42], 14 healthy individuals at an average age of 30 years were
separated into three groups. Each group consumed one of 450 ml of 6 g GT (brewed Lipton tea),
250 mg caffeine (amount contained in GT) or water. Flow-mediated dilatation (FMD) of the brachial
artery was then measured at 30, 90, 120 min intervals. FMD significantly increased in the GT group
but were similar in both the caffeine and water control groups suggesting possible benefits of GT on
coronary endothelial function. Zheng et al. [43] identified and quantified the possible effects of a GT
beverage versus a GT extract on human cholesterol profiles by performing a meta-analysis of
14 randomized trials reported in the literature. The researchers concluded that GT consumption had no
significant effect on high density lipoprotein cholesterol in fasting serum but significantly reduced total
cholesterol levels by 7.20 mg/dL and significantly decreased the LDL-cholesterol concentration by
2.19 mg/dL. In reviews by Deka and Vita [35] and Del Rio et al. [36], other epidemiological data
providing evidence for and against GT and cardiovascular health connection are summarized.
6. Obesity and Diabetes
Metabolic syndrome is a multifaceted condition characterized by elevated waist circumference,
dysglycemia, elevated blood pressure, decreased serum high-density lipoprotein-associated cholesterol,
and increased serum triglycerides, i.e., risk factors for diabetes and cardiovascular disease. As
metabolic cases are increasing at an unprecedented rate in the US and throughout other western
countries, there is considerable interest in the potential benefit of tea consumption for prevention of
metabolic syndrome [44]. Numerous in vitro studies and animal models have shown beneficial effects
of GT catechins on several of these risk factors, including reduced body fat, improved glucose
tolerance and maintenance of a healthy cardiovascular system. As studies specific to GT and
cardiovascular health have been discussed in the previous section, select obesity and diabetes related
research will be presented in this section.
Several studies using animal models investigated the possible relationships between GT phenols
and the development of obesity and other related disease risk factors. Bose et al. [45] reported that
three month old obese mice fed a high fat (HF) diet but supplemented with EGCG not only attenuated
the development of metabolic syndrome but also reversed the symptoms. Body weight, body fat, blood
glucose, plasma insulin, plasma cholesterol, inflammatory markers and liver fat were all significantly
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lower in 16 weeks for the mice fed the HF diet + EGCG compared to the control. After receiving a
3.2 g/kg EGCG supplemented diet, the visceral fat weight in the mice decreased 36% in nine weeks
and blood glucose level decreased 22% in four weeks [45]. Sae-tan [46] showed that C57bl/6J mice
fed a HF diet that included EGCG (0.32% dietary) for 16 weeks resulted in increased gene expression
(1.4- to 1.9-fold) of several proteins involved in mitochondrial fatty acid oxidation, including nuclear
respiratory factor 1, medium chain acyl coA decarboxylase, uncoupling protein 3, and peroxisome
proliferator responsive element α. In addition, increased lipids in the fecal material of the mice
were reported. Another proposed mechanism included modulation of fat lost via an EGCG link.
Lee et al. [47] tested the hypothesis that EGCG promotes triacylglycerol hydrolysis by increasing gene
expression of hormone sensitive lipase. In this study, lipid accumulation in 3T3-L1 adipocytes
decreased significantly after a 24 h treatment with 10 μM EGCG while cell viability was retained.
Richard et al. [48], used male-deficient (ob/ob) mice and their lean counterparts (mice C57BL/6J mice)
to investigate whether regular decaffeinated green tea intake affected body weight and lipid profiles.
GT consumption resulted in significantly lower weight gain in the obese mice and associated
cholesterolemia, triglyceridemia, and adiponectin concentrations but did not adversely affect the
lean model.
Cao et al. [49] determined the possible molecular mechanistic connection between GT catechins
using a high-fructose fed mice model. This study showed that 1–2 g of GT extracts influenced gene
expression of several important regulators of glucose intake and insulin signal pathways. In a similar
study, Hininger-Favier et al. [50] demonstrated the effects of GT extracts on insulin sensitivity using
Wistar rats fed a high-fructose diet (FD) without or with 1 or 2 g of GT supplements for six weeks.
The FD fed rats developed insulin resistance while rats fed GT supplements did not. Additionally, the
rats fed the GT supplement presented with decreased levels of plasma lipid peroxidation, sulfhydryl
group oxidation, and DNA oxidative damage. A recent study by Ma et al. [51] revealed tyrosine
phosphatase (purified from E. coli) was inhibited in response to a GT extract. As a down regulator of
both the insulin and leptin signaling pathways, inhibitors of tyrosine phosphatase are considered
promising approaches to treat diabetes and obesity.
Other studies using human subjects of Asian descent have shown the benefits of GT intake in terms
of reducing risk factors for obesity and diabetes [52–54]. In particular, the Ohsaki study [54], which
followed 40,530 Japanese adults (aged from 40 to 79) for 11 years, revealed a strong inverse
association between GT consumption and cardiovascular disease mortality. Recently, researchers at the
Oklahoma State University compared body weight, lipids and lipid peroxidation in 35 obese subjects
provided either a product with or without a GT extractable [55]. These results supported the Ohsaki
study again positively correlating GT intake with decreased body weight, body mass index and
biomarkers for lipid peroxidation (malondialdehyde and hydroxynonenals).
7. Cancer
According to Khan and Mukhtar [56], 765 reports have been published showing the potential of
GT polyphenols as cancer chemoprevention agents. Therefore, only a sample of those studies is
provided in this section (also refer to Table 4). For example, Ohga et al. [57] studied GT-EGCG as a
therapeutic treatment against several different cancer cell lines. While EGCG had no adverse effect on
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normal endothelial cells, it did exert anti-angiogenic properties by selectively suppressing the
migration of tumor-associated endothelial cells and endothelial progenitor cells. Kato et al. [58]
studied the response of the RECK gene, a novel tumor suppressor gene, in oral squamous cell
carcinoma cell lines (oral cancer cell) treated with EGCG. The hypermethylation status of the RECK
gene was partially reversed by EGCG whereas the gene expression level of RECK mRNA was
significantly enhanced.
A recent in vitro study showed that GT-EGCG inhibited the growth of advanced prostate cancer by
competitively binding to the androgen receptor (AR) and interrupting the gene expression regulated by
AR [59]. EGCG acted at multiple levels including inhibiting interdomain N-C termini interaction,
repressing the prostate cancer related mutant T877A and eventually inhibiting cancer cell growth.
Lee et al. [60] obtained similar results using a prostate cancer cell line in response to GT catechins.
The researchers proposed that catechins modulated AR acetylation was modulated in the presence of
GT catechins thereby inhibiting the translocation of the AR protein to the nucleus. The activity was
comparable to that exhibited by anti-histone acetyltransferase.
Although the cited studies were conducted with experimental cell models, many others have
included tissues collected from human clinic trials (animal and human). By using six tumor related
genes in 106 gastric cancer patients, Yuasa et al. [61] showed that methylation of homeobox
transcription factor and bone morphogenetic protein 2 were inversely correlated with GT intake.
Thangapazham et al. [62] used both a cell system and an animal model to study the inhibitory effect of
GT polyphenols, with an emphasis on EGCG, on human breast cancer cells. The phenol treatments
resulted in down regulating cancer related genes and inhibiting cancer cell proliferation. Moreover, GT
polyphenols and EGCG induced apoptosis in cancer cells of an athymic nude mice model. In another
animal study, Henning et al. [63] xenotransplanted human prostate tumor into severe combined
immunodeficiency (SCID) mice and then replaced water with brewed GT for 13 weeks. Tumor volume,
oxidized DNA and protein damage in tumor tissue were all significantly reduced with GT consumption.
Decreased expression of hypoxia-inducible factor 1-alpha, vascular endothelial growth factor and
tumor 5-cytosine DNA methyltransferase 1 mRNA also occurred [63].
Other studies have focused on the general effect of GT beverage consumption on cancer prevention.
Bettuzzi et al. [64] conducted a one-year double blind clinical trial on men with high-grade prostate
intraepithelial neoplasia. Among the volunteers who were given catechins, only one tumor was
diagnosed whereas nine cancers were detected among the placebo group. The catechin treated
volunteers received significantly better scores on the international prostate symptom score and
exhibited no significant side or adverse effects. However, in the 11 years of the previously discussed
Ohsaki study, GT consumption did not correlate with decreased cancer related mortality [54].
Although research remains limited in human subjects, the combined (in vitro and in vivo) literature
show the potential of GT to protect against oral, prostate, lung, colorectal cancer, and other target
tissues. Such studies have been presented in several recently published reviews [65–67].
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Table 4. Recent studies on green tea and cancer.

References

Model

Ohga et al. [57]

Human cell lines
A375SM and
HSC3

Kato et al.
[58]

Human cell lines
HSC3, HSC4,
SCC9, SCC25 and
HeLa

Siddiqui et al.
[59]

LNCaP and 22Rν1
cells

Yuasa et al. [61]

Tissue of gastric
cancer patients

Thangapazham
et al. [62]

MDA-MB-231 cell
line and athymic
nude mice model

Henning et al.
[63]

Bettuzzi et al.
[64]

Kuriyama et al.
[54]

Male SCID mice

Men with highgrade prostate
intraepithelial
neoplasia

Japanese adults

Treatment

Dosage

Main outcomes

100 μM

EGCG selectively targeted
tumor-associated endothelial
cells and endothelial progenitor
cells, thereby suppressing their
migration.

EGCG

5, 10, 20, 50 μM

EGCG treatment partially
reversed the hypermethylation
status of the RECK gene.

EGCG

0, 10, 20, 40,
60 μM

EGCG

Brewed GT

EGCG and
GTP

0–10 cups per day

0–200 μg/ml

EGCG competitively binding to
AR and interrupting the gene
expression regulated by AR.
Methylation of CDX2 and
BMP-2 were inversely
correlated with GT intake
EGCG and GTP down regulated
cancer related gene expression
and inhibited proliferation of
cancer cell.

Brewed GT

Tumor volume, oxidative DNA
and protein damage in tumor
tissue were all significantly
reduced with GT consumption.

GT
catechins

600 mg/day

One tumor was diagnosed in
treatment group whereas nine
cancers were detected among
the placebo group. Treated
group received higher score of
international prostate symptom.

Brewed GT

<1, 1–2, 3–4, >5
cups per day

GT consumption did not
significantly associate with
cancer mortality.

EGCG: (−)-epigallocatechin gallate; AR: androgen receptor; GTP: green tea phenols; GT: green tea.

8. Gastrointestinal Health
The human gastrointestinal (GI) tract contains more microorganisms than any other surface of the
human body with the large intestine alone containing approximately 10 14 microorganisms [68].
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Although remarkably constant within an individual over time, the microbiome can be perturbed by
diseases or modulated by probiotic or prebiotic interventions [68–74]. Dietary polyphenols can also
impact the GI microbiome by the time of absorption. Lee et al. [75] have provided extensive
information on the gut microflora in response to GT extracts and their aromatic metabolites. The
results showed that metabolites were produced by the bacteria after exposure to a GT polyphenol rich
extract but their sensitivity towards polyphenols varied among species. The proliferation of “Good”
bacteria (commensal anaerobes), which have been linked to benefits associated with host nutrition and
health, were less affected by the extract but growth of pathogenic bacteria were significantly reduced.
Su et al. [76] studied the effect of a commercial GT extract product containing 94% EGCG on three
pathogenic bacteria (Staph. Aureus and Strep. Pyogenes), E. coli, and three probiotic bacteria
(L. acidophilus, B. animalis and L. casei). The growth of all three pathogens was inhibited by GT at
significantly lower levels (minimum inhibition concentration (MIC) of 100 μg/mL GT) compared to
the three probiotic bacteria (MIC >800 μg/mL). Moreover, a synergistic effect between the probiotics
and GT product was reported resulting in reduced growth of the pathogenic bacteria. The GT MIC
value for E. coli was comparable to that of the probiotic bacteria. These results are consistent with a
later study demonstrating that a GT extract inhibited probiotic bacteria and E. coli indiscriminately [77].
Alternatively, Molan et al. [78] compared two types of GT with different mineral composition.
Exposure to a Chinese GT only slightly increased the growth of L. rhamnosus but had no effect on
B. breve. However, the selenium-containing GT positively influenced the growth of both organisms
indicating that the selenium content in GT could be a major factor in promoting probiotic
bacterial growth.
9. Bioavailability
Research on the bioavailability of GT polyphenols is essential in order to understand their health
promoting mechanisms. However, such studies have typically used cell models under certain digestion
conditions while animal and human clinical trials remain limited. Nonetheless, Green et al. [79]
conducted an in vitro digestive recovery experiment with EC, EGC, EGCG and ECG by subjecting
each to a digestion protocol that mimicked the gastric and small intestinal environment. The results
showed poor recovery of the pure catechins (<10%) after exposure to the digestion process.
Conversely, a more recent study demonstrated that GT catechins are highly bioavailable [80]. In this
study, plasma and urine samples were collected from ten healthy men before and after ingestion of
500 mL GT beverage containing 648 μmol of flavan-3-ols over a 24 h period. A Cmax of 29~126 nM
occurred in the plasma at 1.6~2.3 h (Tmax) post ingestion indicating that absorption occurred in the
small intestine. Analysis of the urine samples showed 11.4% recovery of EGC and 28.5% of EC. The
researchers also noted that accurate quantification of catechins bioavailability cannot be accessed
solely by Cmax and T max values because flavan-3-ols metabolites rapidly circulate in the system.
Roowi et al. [81] studied flavan-3-ols degradation in the large intestine by incubating GT-EC, EGC,
and EGCG with human fecal samples. The results showed degradation of the flavan-3-ols
at concentrations equivalent to 40% of the initial intake. A follow-up study completed by
Calani et al. [82] identified GT flavan-3-ol metabolites in the urine of 20 volunteers. For the first time,
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six colonic metabolites were recovered supporting the important role of colonic microbiota in the
digestion of GT flavan-3-ol. The mean bioavailability was approximately 62% after 48 h.
Green tea polyphenols bioavailability can be enhanced with food additives or by ingestion through
different forms. By combining a catechin extract with food additives (ascorbic acid and sucrose),
Peters et al. [83] showed increased catechin absorption (from 61.0 pmol·h/L plasma to 181.8 pmol·h/L
plasma) using a digestion/Caco-2 cell model. Henning et al. [84] showed increased bioavailability
of GT flavonoids in healthy humans when supplemented as a capsule. In yet another study,
Chow et al. [85] determined the oral bioavailability of GT catechins using human volunteers randomly
assigned to different dose groups and administered a catechin supplement in capsule form with or
without a breakfast. Analyses of tea catechin levels in plasma and urine showed that bioavailability
was greater under fasting conditions.
GT phenols (either free, conjugated or bound) bioavailability is thus dependent upon the food
vehicle (beverage or extract) or upon other foods consumed [86]. However, there also remains a
critical lack of information on the interactions of GT catechins in the complex matrix in terms of their
physicochemical properties [86]. Additionally, GT phenols, particularly the catechins, readily undergo
biotransformation via methylation, glucuronidation, sulfation, and ring fission [87], which can affect
their health benefiting properties, their site of absorption and multiple host related factors (e.g., gender,
age, genetics, etc.) [88]. For more information on the bioavailability—biotransformation of phenolic
based compounds, including the tea constituents, and their relationship to health, the reader is referred
to other comprehensive reviews [36,86–88].
10. Conclusions
Evidence supporting the health benefits of GT intake, with an emphasis on the catechins, has been
accumulating at an unprecedented rate over the past decade, including its ability to prevent or
remediate inflammation, atherosclerosis, cancer, obesity and diabetes. The mechanisms by which GT
may exert their effects have also been studied using different experimental designs and approaches.
For example, it is widely agreed that phenols protect against cellular oxidative stress albeit no longer
as free radical scavengers or chelators of redox metals but rather as cell signaling agents of
endogenous responses. However, most GT antioxidative related research has been completed in vitro.
Adding to the uncertainty of where and when GT polyphenols accumulate in or pass through the body,
it is questionable that the same antioxidant effect in vitro will be similar to in vivo results. Moreover,
in vivo studies are difficult if not impossible due to the current lack of methods to reliably measure
ROS levels. By contrast, other studies have shown the GT pro-oxidant activity promotes endogenous
antioxidant systems and thus increases antioxidant enzymes expression. Given that more evidence is
available on the ability of GT polyphenols to modulate gene expression and cell signaling via animal
and human studies, this mechanism may be more important in terms of preventing cancer, metabolic
disorders, etc. However, more questions need to be answered: Where do GT polyphenols go? Do they
stay, and for how long? How do other food matrices (such as caffeine, proteins, carbohydrates) affect
the health promoting properties of GT? The choice of cell or animal models and how they relate to
humans, dosages, introduction of other dietary agents and the analytical approach used should be
carefully considered. Extensive meta-analysis of the existing data may aid in answering these
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questions. Moreover, the effect of GT on the GI microbiome and vice versa cannot be ignored in the
context of their seemingly symbiotic relationship. Lastly, GT catechins have received the major focus
of study while other polyphenols have been largely neglected. However, as the emphasis of
understanding synergisms among nutraceuticals is growing, it is expected that more studies will focus
on the possible roles that GT polyphenols play in concert to protect against specific cellular stresses or
diseases. Nonetheless, the current studies suggest that the GT agricultural base will continue to shift
from one that produces a highly popular beverage to one that also includes GT as a potent health
promoting food.
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

Khokhar, S.; Magnusdottir, S.G.M. Total phenol, catechin, and caffeine contents of teas
commonly consumed in the United Kingdom. J. Agric. Food Chem. 2002, 50, 565–570.
Moxham, R. Tea: Addiction, Exploitation, and Empire; Carroll & Graf Publishers: New York,
NY, USA, 2003.
Pettigrew, J. The Tea Companion: A Connoisseur’s Guide, 1st ed.; Running Press Book
Publishers: Philadelphia, PA, USA, 2004.
Li, X. Study on the Competitiveness of Chinese Tea in the Global Market. Master’s Thesis,
Nanjing Agricultural University, Nanjing, China, 2004.
FAO Web site. Available online: http://faostat3.fao.org/home/index.html (accessed on
18 September 2012).
Singh, B.N.; Shankar, S.; Srivastava, R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG):
Mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011, 82, 1807–1821.
Butt, M.S.; Sultan, M.T. Green tea: Nature’s defense against malignancies. Crit. Rev. Food Sci.
Nutr. 2009, 49, 463–473.
Cabrera, C.; Artacho, R.; Giménez, R. Beneficial effects of green tea—A review. J. Am. Coll.
Nutr. 2006, 25, 79–99.
Balentine, D.A.; Wiseman, S.A.; Bouwens, L.C.M. The chemistry of tea flavonoids. Crit. Rev.
Food Sci. Nutr. 1997, 37, 693–704.
Lin, L.Z.; Chen, P.; Harnly, J.M. New phenolic components and chromatographic profiles of
green and fermented teas. J. Agric. Food Chem. 2008, 56, 8130–8140.
Hatanaka, A. The biogeneration of green odour by green leaves. Phytochemistry 1993, 34,
1201–1218.
Wang, Y.; Wei, X.; Jin, Z. Structure analysis of a neutral polysaccharide isolated from green tea.
Food Res. Int. 2009, 42, 739–745.
Chen, H.; Zhang, M.; Qu, Z.; Xie, B. Antioxidant activities of different fractions of
polysaccharide conjugates from green tea (Camellia sinensis). Food Chem. 2007, 106, 559–563.
Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free
Radic. Biol. Med. 2010, 48, 749–762.
Kowaltowski, A.J.; Souza-Pinto, N.C.; Castilho, R.F.; Vercesi, A.E. Mitochondria and reactive
oxygen species. Free Radic. Biol. Med. 2009, 47, 333–343.

Agriculture 2012, 2

408

16. Schroeder, E.K.; Kelsey, N.A.; Doyle, J.; Breed, E.; Bouchard, R.J.; Loucks, F.A.;
Linseman, D.A. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a
selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons.
Antioxid. Redox Signal. 2009, 11, 469–480.
17. Guo, S.; Yan, J.; Yang, T.; Yang, X.; Bezard, E.; Zhao, B. Protective effects of green tea
polyphenols in the 6-OHDA rat model of Parkinson’s Disease through inhibition of ROS-NO
pathway. Biol. Psychiatry 2007, 62, 1353–1362.
18. Quesada, I.M.; Bustos, M.; Blay, M.; Pujadas, J.; Ardèvol, A.; Salvadó, M.J.; Bladé, C.; Arola, L.;
Fernández-Larrea, J. Dietary catechins and procyanidins modulate zinc homeostasis in human
HepG2 cells. J. Nutr. Biochem. 2011, 22, 153–163.
19. Wei, H.; Meng, Z. Protective effects of epigallocatechin-3-gallate against lead-induced oxidative
damage. Hum. Exp. Toxicol. 2010, 30, 1521–1528.
20. Lambert, J.D.; Elias, R.J. The antioxidant and pro-oxidant activities of green tea polyphenols: A
role in cancer prevention. Arch. Biochem. Biophys. 2010, 501, 65–72.
21. Maeta, K.; Nomura, W.; Takatsume, Y.; Izawa, S.; Inoue, Y. Green tea polyphenols function as
prooxidants to activate oxidative-stress-responsive transcription factors in yeasts. Appl. Environ.
Microbiol. 2007, 73, 572–580.
22. Elbling, L.; Herbacek, I.; Weiss, R.-M.; Jantschitsch, C.; Micksche, M.; Gerner, C.; Pangratz, H.;
Berger, W. Hydrogen peroxide mediates EGCG-induced antioxidant protection in human
keratinocytes. Free Radic. Biol. Med. 2010, 49, 1444–1452.
23. Lin, W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer.
J. Clin. Investig. 2007, 117, 1175–1183.
24. Lumeng, C.N.; Saltiel, A.R. Inflammatory links between obesity and metabolic disease. J. Clin.
Investig. 2011, 121, 2111–2117.
25. Smith, G.R.; Missailidis, S. Cancer, inflammation and the AT1 and AT2 receptors. J. Inflamm.
2004, 1, 1–12.
26. Dona, M.; Dell’Aica, L.; Calabrese, F.; Benelli, R.; Morini, M.; Albini, A.; Garbisa, S. Neutrophil
restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.
J. Immunol. 2003, 170, 4335–4341.
27. Shen, C.-L.; Samathanam, C.; Tatum, O.L.; Graham, S.; Tubb, C.; Cao, J.J.; Dunn, D.M.;
Wang, J.-S. Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of
female rats. Inflamm. Res. 2011, 60, 665–672.
28. Askenasya, N.; Kaminitza, A.; Yarkoni, S. Mechanisms of T regulatory cell function. Autoimmun.
Rev. 2008, 7, 370–375.
29. Wong, C.P.; Nguyena, L.P.; Nohb, S.K.; Braya, T.B.; Brunob, R.S.; Ho, E. Induction of
regulatory T cells by green tea polyphenol EGCG. Immunol. Lett. 2011, 139, 7–13.
30. Tsai, P.-Y.; Ka, S.-M.; Chang, J.-M.; Chen, H.-C.; Shui, H.-A.; Li, C.-Y.; Hua, K.-F.;
Chang, W.-L.; Huang, J.-J.; Yang, S.-S.; et al. Epigallocatechin-3-gallate prevents lupus nephritis
development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3
inflammasome activation. Free Radic. Biol. Med. 2011, 51, 744–754.

Agriculture 2012, 2

409

31. Wu, D.; Guo, Z.; Ren, Z.; Guo, W.; Meydani, S.N. Green tea EGCG suppresses T cell
proliferation through impairment of IL-2/IL-2 receptor signaling. Free Radic. Biol. Med. 2009, 47,
636–643.
32. Ranjith-Kumar, C.T.; Lai, Y.; Sarisky, R.T.; Kao, C.C. Green tea catechin, epigallocatechin
gallate, suppresses signaling by the dsRNA innate immune receptor RIG-I. PLoS One 2010,
5, e12878.
33. Noh, S.U.; Park, Y.M. The effect of green tea polyphenols on macrophage migration inhibitory
factor-associated steroid resistance. Br. Assoc. Dermatol. 2012, 166, 653–657.
34. Ripley, B.J.M.; Fujimoto, M.; Serada, S.; Ohkawara, T.; Nishikawa, T.; Terabe, F.; Naka, T.
Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene
expression. Int. Immunol. 2010, 22, 359–366.
35. Deka, A.; Vita, J.A. Tea cardiovascular disease. Pharmacol. Res. 2012, 64, 136–145.
36. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.E.; Tognolini, M.; Borges, G.; Crozier, A.
Dietary polyphenolics in human health: Structures, bioavailability, and evidence of protective
effects against chronic diseases. Antioxid. Redox Signal. 2012, doi:10.1089/ars.2012.4581.
37. Qin, B.; Polansky, M.M.; Harry, D.; Anderson, R.A. Green tea polyphenols improve cardiac
muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and
inflammation in insulin resistant rats. Mol. Nutr. Food Res. 2010, 54, S14–S23.
38. Lorenz, M.; Urban, J.; Engelhardt, U.; Baumann, G.; Stangl, K.; Stangl, V. Green and black tea
are equally potent stimuli of NO production and vasodilation: New insights into tea ingredients
involved. Basic Res. Cardiol. 2009, 104, 100–110.
39. El Bedoui, J.; Oak, M.H.; Anglard, P.; Schini-Kerth, V.B. Catechins prevent vascular smooth
muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc. Res.
2005, 67, 317–325.
40. Bursill, C.A.; Roach, P.D. Modulation of cholesterol metabolism by the green tea polyphenol
(−)-epigallocatechin gallate in cultured human liver (HepG2) cells. J. Agric. Food Chem. 2006, 54,
1621–1626.
41. Bursill, C.A.; Abbey, M.; Roach, P.D. A green tea extract lowers plasma cholesterol by inhibiting
cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit.
Atherosclerosis 2007, 193, 86–93.
42. Alexopoulos, N.; Vlachopoulos, C.; Aznaouridis, K.; Baou, K.; Vasiliadou, C.; Pietri, P.;
Xaplanteris, P.; Stefanadi, E.; Stefanadis, C. The acute effect of green tea consumption on
endothelial function in healthy individuals. Eur. J. Cardiovasc. Prev. Rehabil. 2008, 15, 300–305.
43. Zheng, X.-X.; Xu, Y.-L.; Li, H.-S.; Liu, X.-X.; Hui, J.; Huang, X.-H. Green tea intake lowers
fasting serum total and LDL cholesterol in adults: A meta-analysis of 14 randomized controlled
trials. Am. J. Clin. Nutr. 2011, 94, 601–610.
44. Sae-Tan, S.; Grove, K.A.; Lambert, J.D. Weight control and prevention of metabolic syndrome by
green tea. Pharmacol. Res. 2012, 64, 146–154.
45. Bose, M.; Lambert, J.D.; Ju, J.; Reuhl, K.R.; Shapses, S.A.; Yang, C.S. The major green tea
polyphenol, (−)-Epigallocatechin-3-Gallate, inhibits obesity, metabolic syndrome, and fatty liver
disease in high-fat-fed mice. J. Nutr. 2008, 138, 1677–1683.

Agriculture 2012, 2

410

46. Sae-Tan, S.; Grove, K.A.; Kennettb, M.J.; Lambert, J.D. (−)-Epigallocatechin-3-gallate increases
the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice. Food
Funct. 2011, 2, 111–116.
47. Lee, M.-S.; Kim, C.-T.; Kim, I.-H.; Kim, Y. Inhibitory effects of green tea catechin on the lipid
accumulation in 3T3-L1 adipocytes. Phytother. Res. 2009, 23, 1088–1091.
48. Richard, D.; Kefi, K.; Barbe, U.; Poli, A.; Bausero, P.; Visioli, F. Weight and plasma lipid control
by decaffeinated green tea. Pharmocol. Res. 2009, 59, 351–354.
49. Cao, H.; Hininger-Favier, I.; Kelly, M.A.; Benaraba, R.; Dawson, H. D.; Coves, S.; Roussel, A.M.;
Anderson, R.A. Green tea polyphenol extract regulates the expression of genes involved in
glucose uptake and insulin signaling in rats fed a high fructose diet. J. Agric. Food Chem. 2007,
55, 6372–6378.
50. Hininger-Favier, I.; Benaraba, R.; Coves, S.; Anderson, R.A.; Roussel, A.M. Green tea extract
decreases oxidative stress and improves insulin sensitivity in an animal model of insulin
resistance, the fructose-fed rat. J. Am. Coll. Nutr. 2009, 28, 355–361.
51. Ma, J.; Li, Z.; Xing, S.; Ho, W.T.; Fu, X.; Zhao, Z.J. Tea contains potent inhibitors of tyrosine
phosphatase PTP1B. Biochem. Biophys. Res. Commun. 2011, 407, 98–102.
52. Oba, S.; Nagata, C.; Nakamura, K.; Fujii, K.; Kawachi, T.; Takatsuka, N.; Shimizu, H.
Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content
in relation to risk of diabetes in Japanese men and women. Br. J. Nutr. 2010, 103, 453–459.
53. Hsu, C.-H.; Tsai, T.-H.; Kao, Y.-H.; Hwang, K.-C.; Tseng, T.-Y.; Chou, P. Effect of green tea
extract on obese women: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr.
2008, 27, 363–370.
54. Kuriyama, S.; Shimazu, T.; Ohmori, K.; Kikuchi, N.; Nakaya, N.; Nishino, Y.; Tsubono, Y.;
Tsuji, I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes
in Japan: The Ohsaki study. J. Am. Med. Assoc. 2006, 296, 1255–1265.
55. Basu, A.; Sanchez, K.; Leyva, M.J.; Wu, M.; Betts, N.M.; Aston, C.E.; Lyons, T.J. Green tea
supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with
metabolic syndrome. J. Am. Coll. Nutr. 2010, 29, 31–40.
56. Khan, N.; Mukhtar, H. Multi-targeted therapy of cancer by green tea polyphenols. Cancer Lett.
2008, 269, 269–280.
57. Ohga, N.; Hida, K.; Hida, Y.; Muraki, C.; Tsuchiya, K.; Matsuda, K.; Ohiro, Y.; Totsuka, Y.;
Shindoh, M. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on
tumor-associated endothelial cells and endothelial progenitor cells. Cancer Sci. 2009, 100,
1963–1970.
58. Kato, K.; Long, N.K.; Makita, H.; Toida, M.; Yamashita, T.; Hatakeyama, D.; Hara, A.; Mori, H.;
Shibata, T. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell
invasion in oral squamous cell carcinoma cells. Br. J. Cancer 2008, 99, 647–654.
59. Siddiqui, I.A.; Asim, M.; Hafeez, B.B.; Adhami, V.M.; Tarapore, R.S.; Mukhtar, H. Green tea
polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 2011, 25,
1198–1207.

Agriculture 2012, 2

411

60. Lee, Y.H.; Kwak, J.; Choi, H.K.; Choi, K.C.; Kim, S.; Lee, J.; Jun, W.; Park, H.J.; Yoon, H.G.
EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by
anti-histone acetyltransferase activity. Int. J. Mol. Med. 2012, doi:10.3892/ijmm.2012.966.
61. Yuasa, Y.; Nagasaki, H.; Akiyama, Y.; Hashimoto, Y.; Takizawa, T.; Kojima, K.; Nakachi, K.
DNA methylation status is inversely correlated with green tea intake and physical activity in
gastric cancer patients. Int. J. Cancer 2009, 124, 2677–2682.
62. Thangapazham, R.L.; Singh, A.K.; Sharma, A.; Warren, J.; Gaddipati, J.P.; Maheshwari, R.K.
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human
breast cancer cells in vitro and in vivo. Cancer Lett. 2007, 245, 232–241.
63. Henning, S.M.; Wang, P.; Said, J.; Magyar, C.; Castor, B.; Doan, N.; Tosity, C.; Moro, A.;
Gao, K.; Li, L.; et al. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by
localizing to the tumor and decreasing oxidative stress and angiogenesis. J. Nutr. Biochem. 2012,
23, 1537–1542.
64. Bettuzzi, S.; Brausi, M.; Rizzi, F.; Castagnetti, G.; Peracchia, G.; Corti, A. Chemoprevention of
human prostate cancer by oral administration of green tea catechins in volunteers with high-grade
prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study.
Cancer Res. 2006, 66, 1234–1240.
65. Yang, C.S.; Wang, H.; Li, G.X.; Yang, Z.; Guan, F.; Jin, H. Cancer prevention by tea: Evidence
from laboratory studies. Pharmacol. Res. 2012, 64, 113–122.
66. Yuan, J.-M.; Sun, C.; Butler, L.M. Tea and cancer prevention: Epidemiological studies.
Pharmacol. Res. 2012, 64, 123–135.
67. Chow, H.-H.S.; Hakim, I.A. Pharmacokinetic and chemoprevention studies on tea in
humans. Pharmacol. Res. 2012, 64, 105–112.
68. Flint, H.J.; Duncan, S.H.; Scott, K.P.; Louis, P. Interactions and competition within the microbial
community of the human colon: Links between diet and health. Environ. Microbiol. 2007, 9,
1101–1111.
69. Cani, P.D.; Possemiers, S.; van de Wiele, T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.;
Naslain, D.; Neyrinck, A.; Lambert, D.M.; et al. Changes in gut microbiota control inflammation
in obese mice through mechanism involving GLP-2-driven improvement of gut permeability. Gut
2009, 58, 1091–1103.
70. Corr, S.C.; Li, Y.; Riedel, C.U.; O’Toole, P.W.; Hill, C.; Gahan, C.G.M. Bacteriocin production
as a mechanism for the anti-infective activity of Lactobacillus salivarius UCC118. Proc. Natl.
Acad. Sci. USA 2007, 104, 7617–7621.
71. Lee, Y.K.; Menezes, J.S.; Umesaki, Y.; Mazmanian, S.K. Proinflammatory T-cell responses to
gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA
2011, 108, 4615–4622.
72. Dunne, C.; Murphy, L.; Flynn, S.; O’Mahony, L.; O’Halloran, S.; Feeney, M.; Morrissey, D.;
Thornton, G.; Fitzgerald, G.; Daly, C.; et al. Probiotics: from myth to reality. Demonstration of
functionality in animal models of disease and in human clinical trials. Antonie van Leeuwenhoek.
1999, 76, 279–292.

Agriculture 2012, 2

412

73. Crittenden, R.; Playne, M.J. Modifying the human intestinal microbiota with prebiotics. In
Gastrointestinal Microbiology; Ouwehand, A.C., Vaughan, E.E., Eds.; Taylor & Francis Inc.:
New York, NY, USA, 2006; pp. 285–314.
74. Khoruts, A.; Dicksved, J.; Jansson, J.K.; Sadowsky, M.J. Changes in the composition of the
human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated
diarrhea. J. Clin. Gastroenterol. 2010, 44, 354–360.
75. Lee, H.C.; Jenner, A.M.; Low, C.S.; Lee, Y.K. Effect of tea phenolics and their aromatic fecal
bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157, 876–884.
76. Su, P.; Henriksson, A.; Nilsson, C.; Mitchell, H. Synergistic effect of green tea extract and
probiotics on the pathogenic bacteria, Staphylococcus aureus and Streptococcus pyogenes. World
J. Microbiol. Biotechnol. 2008, 24, 1837–1841.
77. Sutherland, J.; Miles, M.; Hedderley, D.; Li, J.; Devoy, S.; Sutton, K.; Lauren, D. In vitro effects
of food extracts on selected probiotic and pathogenic bacteria. Int. J. Food Sci. Nutr. 2009, 60,
717–727.
78. Molan, A.L.; Flanagan, J.; Wei, W.; Moughan, P.J. Selenium-containing green tea has higher
antioxidant and prebiotic activities than regular green tea. Food Chem. 2009, 114, 829–835.
79. Green, R.J.; Murphy, A.S.; Schulz, B.; Watkins, B.A.; Ferruzzi, M.G. Common tea formulations
modulate in vitro digestive recovery of green tea catechins. Mol. Nutr. Food Res. 2007, 51,
1152–1162.
80. Stalmach, A.; Troufflard, S.; Serafini, M.; Crozier, A. Absorption, metabolism and excretion of
Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res. 2009, 53, S44–S53.
81. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, W.E.J.; Edwards, C.A.; Crozier, A. Green tea
flavan-3-ols: Colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food
Chem. 2010, 58, 1296–1304.
82. Calani, L.; Del Rio, D.; Luisa Callegari, M.; Morelli, L.; Brighenti, F. Updated bioavailability and
48 h excretion profile of flavan-3-ols from green tea in humans. Int. J. Food Sci. Nutr. 2012, 63,
513–521.
83. Peters, C.M.; Green, R.J.; Janle, E.M.; Ferruzzi, M.G. Formulation with ascorbic acid and sucrose
modulates catechin bioavailability from green tea. Food Res. Int. 2010, 43, 95–102.
84. Henning, S.M.; Niu, Y.; Lee, N.H.; Thames, G.D.; Minutti, R.R.; Wang, H.; Go, V.L.W.;
Heber, D. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea,
black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80, 1558–1564.
85. Chow, H.-H.S.; Hakim, I.A.; Vining, D.R.; Crowell, J.A.; Ranger-Moore, J.;
Chew, W.M.; Celaya, C.A.; Rodney, S.R.; Hara, Y.; Alberts, D.A. Effects of dosing condition on
the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in
healthy individuals. Clin. Cancer Res. 2005, 11, 4627–4633.
86. Archivio, M.D.; Filesi, C.; Rosaria, V.; Scazzocchio, B.; Masella, R. Bioavailability of the
polyphenols: Status and controversies. Int. J. Mol. Sci. 2010, 11, 1321–1342.
87. Sang, S.; Lambert, J.D.; Ho, C.-T.; Yang, C.S. The chemistry and biotransformation of tea
constituents. Pharmacol. Res. 2011, 64, 87–99.

Agriculture 2012, 2

413

88. Hollman, P.C.H. Absorption, bioavailability and metabolism of flavonoids. Pharm. Biol. 2004,
42, 74–83.
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).

